Suppr超能文献

新型化合物对恶性疟原虫的体外抗疟活性以及对伯氏疟原虫的体内抗疟活性评估。

Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.

作者信息

Tedlaouti F, Gasquet M, Delmas F, Timon-David P, Madadi N E, Vanelle P, Maldonado J

机构信息

Laboratoire de Parasitologie, Faculté de Pharmacie, Marseille, France.

出版信息

J Pharm Belg. 1990 Sep-Oct;45(5):306-10.

PMID:2086754
Abstract

Various hydrazones of thiophene carboxaldehyde were tested in vitro on two Plasmodium falciparum strains and in vivo on mice experimentally infected with Plasmodium berghei. These hydrazones were obtained by condensation of appropriate hydrazines with thiophene-2-carboxaldehyde (series 1), thiophene-3- carboxaldehyde (series 2) and 5-Nitrothiophene-2-carboxaldehyde (series 3). Compounds of series 3, 5-Nitrothiophene-2-carboxaldehyde presented significant effects in vitro. In vivo tests confirmed the antimalarial activity observed in vitro with two compounds of this series.

摘要

对噻吩甲醛的各种腙进行了体外对两种恶性疟原虫菌株的测试以及体内对实验感染伯氏疟原虫的小鼠的测试。这些腙是通过适当的肼与噻吩 -2-甲醛(系列1)、噻吩 -3-甲醛(系列2)和5-硝基噻吩 -2-甲醛(系列3)缩合得到的。系列3的化合物5-硝基噻吩 -2-甲醛在体外呈现出显著效果。体内试验证实了该系列的两种化合物在体外观察到的抗疟活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验